Send feedback

MOGS p.Gly125=

c.375C>G · rs369972550 · VCV745352

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0329%, mid)
Conditions
1
MOGS-congenital disorder of glycosylation

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 0.9GERP -3.4, phastCons 0.32
Overall
CADD10.77PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0329% Middle Eastern · 2/6,082 alleles
Filtering AF 0.0141% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0112%
Overall 0.00732% 118/1,612,962 alleles · ultra-rare exomes 106/1,460,714 · genomes 12/152,248 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0372% 2,688
Middle Easterngrpmax 0.0329% 3,041
Admixed American 0.0233% 4,285
European (non-Finnish) 0.00738% 13,557
Remaining individualsnot grpmax-eligible 0.0032% 31,212
African / African-American 0.00133% 74,938
South Asian 0.0011% 91,062

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MOGS
Protein
p.Gly125=
Coding
c.375C>G
MANE Select
NM_006302
dbSNP
rs369972550
Type
single nucleotide variant
Location
chr2:74464700 (GRCh38)
Gene constraint
LOEUF 0.85 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 92.42
Residue 125
the 'required for endoplasmic reticulum targeting' region
Full MOGS gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

MOGS-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For MOGS-CDG (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mogs-p-gly125 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown